1. The CIMP Phenotype inBRAFMutant Serrated Polyps from a Prospective Colonoscopy Patient Cohort
    Winnie C. Fernando et al, 2014, Gastroenterology Research and Practice CrossRef
  2. Clinical, Pathological, and Molecular Characteristics of CpG Island Methylator Phenotype in Colorectal Cancer: A Systematic Review and Meta-analysis
    Shailesh M. Advani et al, 2018, Translational Oncology CrossRef
  3. Immune environment in serrated lesions of the Colon: intraepithelial lymphocyte density, PD-1, and PD-L1 expression correlate with serrated neoplasia pathway progression
    Gabriel Acosta-Gonzalez et al, 2018, Human Pathology CrossRef
  4. CpG Island Methylation in Sessile Serrated Adenomas Increases With Age, Indicating Lower Risk of Malignancy in Young Patients
    Cheng Liu et al, 2018, Gastroenterology CrossRef
  5. The proto CpG island methylator phenotype of sessile serrated adenomas/polyps
    Hannah R. Parker et al, 2018, Epigenetics CrossRef
  6. B-RAF mutation and accumulated gene methylation in aberrant crypt foci (ACF), sessile serrated adenoma/polyp (SSA/P) and cancer in SSA/P
    A Inoue et al, 2015, Br J Cancer CrossRef
  7. Clinicopathological factors associated with BRAF ‐V600E mutation in colorectal serrated adenomas
    Antonio Travaglino et al, 2019, Histopathology CrossRef
  8. Can the rate and location of sessile serrated polyps be part of colorectal Cancer disparity in African Americans?
    Mehdi Nouraie et al, 2019, BMC Gastroenterol CrossRef
  9. DNA methylation changes that precede onset of dysplasia in advanced sessile serrated adenomas
    Cheng Liu et al, 2019, Clin Epigenet CrossRef
  10. Establishing a Biological Profile for Interval Colorectal Cancers
    Amy L. Cisyk et al, 2014, Dig Dis Sci CrossRef
  11. DNA methylation alterations of AXIN2 in serrated adenomas and colon carcinomas with microsatellite instability
    Yuta Muto et al, 2014, BMC Cancer CrossRef
  12. DNA methylation accumulation and its predetermination of future cancer phenotypes
    A. Kaneda et al, 2014, Journal of Biochemistry CrossRef
  13. Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway
    Eiji Sakai et al, 2016, Int. J. Cancer CrossRef
  14. Loss of Hes1 Differentiates Sessile Serrated Adenoma/Polyp From Hyperplastic Polyp
    Min Cui et al, 2016, The American Journal of Surgical Pathology CrossRef
  15. TP53 mutation at early stage of colorectal cancer progression from two types of laterally spreading tumors
    Eiji Sakai et al, 2016, Cancer Sci CrossRef
  16. Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer
    Shailesh Mahesh Advani et al, 2019, BMC Cancer CrossRef
  17. Receptor tyrosine kinase fusions act as a significant alternative driver of the serrated pathway in colorectal cancer development
    Anthony W‐H Chan et al, 2020, J. Pathol. CrossRef
  18. Cell-surface markers for colon adenoma and adenocarcinoma
    Kamini Sewda et al, 2016, Oncotarget CrossRef
  19. Evolving pathologic concepts of serrated lesions of the colorectum
    Jung Ho Kim et al, 2020, J Pathol Transl Med CrossRef